Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) shares shot up 11.1% on Monday. The company traded as high as $0.25 and last traded at $0.25. Approximately 200 shares traded hands during trading, a decline of 99% from the average session volume of 20,342 shares. The stock had previously closed at $0.2250.
Cell MedX Trading Up 11.1%
The firm’s 50-day moving average is $0.22 and its two-hundred day moving average is $0.30.
Cell MedX Company Profile
Cell MedX Inc is a healthcare technology company associated with the development of noninvasive wellness and therapeutic technologies. Its best-known product is the eVox System, which has been described as a biofeedback and electrotherapy device designed to support relaxation, stress management, and general wellness.
The company has also promoted technologies intended to assist with exercise, circulation, pain management, and other health-related applications. Publicly available information about the company’s current product offerings, commercial operations, geographic reach, and regulatory status is limited.
Cell MedX has historically operated in the medical technology and wellness sectors under the OTCMKTS:CMXC symbol.
See Also
- Five stocks we like better than Cell MedX
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
